Understanding mechanisms of inhaled toxicants: Implications for replacing default factors with chemical-specific data

被引:18
作者
Bogdanffy, MS [1 ]
Jarabek, AM [1 ]
机构
[1] US EPA,NATL CTR ENVIRONM ASSESSMENT MD52,RES TRIANGLE PK,NC 27711
关键词
nose; lung; inhalation toxicity; risk assessment; dosimetry modeling;
D O I
10.1016/0378-4274(95)03603-2
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Assessing risk of inhaled materials is a challenging endeavor because of the profound interspecies differences in respiratory tract anatomy, physiology, and biochemistry. Recent advances in the availability of mechanistic data and mathematical models for describing dosimetry behavior of particles and gases has lead to improvements in default approaches to risk assessment of inhaled materials. An overview of some of the more well-understood differences between species in factors controlling dosimetry and response, and the default approach of the U.S. Environmental Protection Agency that accounts for many of these factors, are presented. The default methodology also creates a framework which inhalation toxicologists can use to direct research at reducing uncertainty in risk assessments that might otherwise be handled through default uncertainty factors. The optimal approach to risk assessment is to develop chemical-specific mode of action and dosimetry data that can be used quantitatively to replace the entire default approach. The toxicology of vinyl acetate and recent efforts to develop data to supplant assumptions made in the default approach are presented. The conclusion is drawn that the future of inhalation toxicity risk assessment lies in reducing uncertainties associated with interspecies extrapolation and that to do this effectively requires approaches to toxicology that are outside of routine testing paradigms, and are aimed at elucidating mechanisms of action through hypothesis-driven research.
引用
收藏
页码:919 / 932
页数:14
相关论文
共 46 条
[1]   TISSUE DOSIMETRY, PHARMACOKINETIC MODELING, AND INTERSPECIES SCALING FACTORS [J].
ANDERSEN, ME ;
CLEWELL, H ;
KRISHNAN, K .
RISK ANALYSIS, 1995, 15 (04) :533-537
[2]   BENCHMARK DOSE WORKSHOP - CRITERIA FOR USE OF A BENCHMARK DOSE TO ESTIMATE A REFERENCE DOSE [J].
BARNES, DG ;
DASTON, GP ;
EVANS, JS ;
JARABEK, AM ;
KAVLOCK, RJ ;
KIMMEL, CA ;
PARK, C ;
SPITZER, HL .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1995, 21 (02) :296-306
[4]  
BOGDANFFY MS, 1995, UNPUB ANAL VINYL ACE
[5]  
BOGDANFFY MS, 1995, INHAL TOXICOL S, V6, P205
[6]  
BRAIN JD, 1983, AM REV RESPIR DIS, V128, pS87
[7]  
CRAPO JD, 1983, AM REV RESPIR DIS, V128, pS42
[8]   COMPARISON OF THE BIOTRANSFORMATION OF 1,3-BUTADIENE AND ITS METABOLITE, BUTADIENE MONOEPOXIDE, BY HEPATIC AND PULMONARY TISSUES FROM HUMANS, RATS AND MICE [J].
CSANADY, GA ;
GUENGERICH, FP ;
BOND, JA .
CARCINOGENESIS, 1992, 13 (07) :1143-1153
[9]   NASAL CAVITY ENZYMES INVOLVED IN XENOBIOTIC METABOLISM - EFFECTS ON THE TOXICITY OF INHALANTS [J].
DAHL, AR ;
HADLEY, WM .
CRITICAL REVIEWS IN TOXICOLOGY, 1991, 21 (05) :345-372
[10]   SYMPOSIUM OVERVIEW - COMPARATIVE DOSIMETRY OF INHALED MATERIALS - DIFFERENCES AMONG ANIMAL SPECIES AND EXTRAPOLATION TO MAN [J].
DAHL, AR ;
SCHLESINGER, RB ;
HECK, HD ;
MEDINSKY, MA ;
LUCIER, GW .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1991, 16 (01) :1-13